Electrophysiology device developer EP MedSystems of West Berlin, NJ, has begun a new clinical study, called the intracardiac echocardiography-guided cardioversion to help interventional procedures (ICE-CHIP) trial.
The ICE-CHIP trial is a sequential phase I and phase II worldwide clinical trial, which compares the cardiac imaging capabilities of ICE during a cardiac catheterization procedure with standard transesophageal echocardiography, which is a separate standalone procedure in phase I. In phase II, immediate ICE-guided cardioversion is compared to a conventional cardioversion strategy of greater than three weeks of warfarin therapy in patients with atrial fibrillation (AF).
Both phases are designed to reduce the need for additional procedures and prolonged delays in cardioversion therapy for AF patients, the company said. The ICE technique can be incorporated into standard cardiac catheterization and electrophysiologic procedures that are performed by cardiologists, according to EP MedSystems.
This is EP MedSystems' first clinical trial involving intracardiac ultrasound.
By AuntMinnie.com staff writers
May 4, 2005
Related Reading
EP MedSystems boosts sales, trims losses in 2004, March 11, 2005
EP MedSystems nets $4.5 million, December 16, 2004
EP MedSystems posts robust Q3, October 27, 2004
EP MedSystems gets CE Mark, July 27, 2004
EP MedSystems hikes revenue, trims losses in Q1, May 7, 2004
Copyright © 2005 AuntMinnie.com
